Sponsored Research
Adrian Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "PCORnet Governance, Collaboration, and Operations to Facilitate PCORnet(R) Studies of National Scope." Total funding will be $6,998,274.
Raymond Kim of Cardiology has received a sub-award (1R01HL171150-01A1) through the Houston Methodist Research Institute for a project entitled "Sudden Death Risk Assessment and Mechanistic Insights in Arrhythmic Mitral Valve Prolapse Using Cardiac MRI and Circulating Proteomic Biomarkers." Total funding will be $151,459.
Gedion Ngeno of Cardiology has received a sub-award () through the Indiana University for a project entitled "Designing and Implementing a Registry for Patients with Structural Heart Disease at the Moi Teaching and Referral Hospital(MTRH) in Eldoret, Kenya." Total funding will be $247,284.
Manesh Patel of Cardiology has received an award from the California Health Care Foundation for a project entitled "HAIP Practice Network Cohort in California." Total funding will be $30,000.
Sudarshan Rajagopal of Cardiology has received an award from the American Heart Association for a project entitled "Engineering a New Class of Therapies for Heart Failure." Total funding will be $550,000.
Mitchell Horwitz of Cell Therapy has received a sub-award () through the National Marrow Donor Program for a project entitled "A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Haploidentical Related, Partially HLA-Mismatched, or Matched Unrelated Bone Marrow for Newly Diagnosed Patients with Severe Aplastic Anemia." Total funding will be $97,494.
David A. Bader (Mentor: Matthew Hirschey) of Endocrinology has received an award (1F32-CA298657-01) from the National Institutes of Health for a project entitled "Manipulating Sex Hormone Signaling for Therapeutic Benefit in Liver Cancer." Total funding will be $251,784.
Carey Anders of Oncology has received an award (HT9425-25-1-0244-BC240341) from the Department of Defense for a project entitled "Breast Cancer Brain Metastases: Integrating Immunogenomic and Phenotypic Vulnerabilities to Improve Outcomes." Total funding will be $161,000.
Jason Somarelli of Oncology has received a sub-award (7R37-CA278826-02) through the Wake Forest University School Of Medicine for a project entitled "Mitochondrial bioenergetics and colorectal cancer." Total funding will be $63,875.
Laurie Snyder of Pulmonary has received an award from the Cystic Fibrosis Foundation for a project entitled "Understanding the Role of Cytomegalovirus in the Pathogenesis and Prevention of CLAD." Total funding will be $112,000.
Laurie Snyder of Pulmonary has received an award from the Cystic Fibrosis Foundation for a project entitled "Duke UNC Cystic Fibrosis Tissue Procurement Partnership 2025-2026." Total funding will be $9,041.
Industry Sponsored Clinical Trials
Adam Devore of Cardiology has received an award from Merck Sharp & Dohme LLC. for a project entitled "Merck - CHA - Guidelines Implementation Study - Industry." Total funding will be $987,557.
Marat Fudim of Cardiology has received an award from Cardiosense, Inc. for a project entitled "SEISMIC-HF II Clinical Validation Study." Total funding will be $76,911.
Michel Khouri of Cardiology has received a sub-award () through Brigham and Women's Hospital for a project entitled "REVEAL." Total funding will be $167,071.
Danielle Brander of Cell Therapy has received an award from AbbVie Inc. for a project entitled "A Phase 1 Study of ABBV-453 in Adult Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)." Total funding will be $1,053,602.
Cristina Gasparetto of Cell Therapy has received an award from AbbVie Inc. for a project entitled "Relapsed or Refractory Multiple Myeloma: ABBV-383 vs Standard Available Therapies in Subjects with RRMM (3L+ RRMM Monotherapy Study)." Total funding will be $437,985.
Jonathan Campbell of Endocrinology has received an award from Fractyl Health for a project entitled "Preclinical studies to gain mechanistic insight into how Rejuva regulates islet function." Total funding will be $68,121.
Amreen Dinani of Gastroenterology has received an award from Clinetic, Inc for a project entitled "ELF Study Pro00115897. Implementation of ELF in Type 2 Diabetes Clinics to Identify Patients with Liver Fibrosis Secondary to Metabolic Dysfunction Associated Steatotic Liver Disease.." Total funding will be $76,100.
Marilyn Telen of Hematology has received an award from Novo Nordisk, Inc. for a project entitled "NN7535-7822 FLORAL." Total funding will be $216,272.
Opeyemi Olabisi of Nephrology has received an award from Maze Therapeutics for a project entitled "Maze Therapeutics MZE829-201: An Open-Label Phase 2 Study to Evaluate the Safety, Tolerability, and Effect on Albuminuria of MZE829 in Adults with Proteinuric Chronic Kidney Disease and the APOL1 High Risk Genotype." Total funding will be $81,319.
Scott Sanoff of Nephrology has received an award from Biogen MA, Inc. for a project entitled "A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 3 Trial Evaluating the Efficacy and Safety of Felzartamab in Kidney Transplant Recipients with Late Antibody-Mediated Rejection (AMR) (TRANSCEND)." Total funding will be $216,695.
Laura Alder of Oncology has received an award from NTT DATA Americas, Inc. for a project entitled "A randomized pilot study comparing the feasibility of using a virtual agent vs. an off-site human agent to onboard oncology patients to remote patient AI monitoring devices." Total funding will be $222,427.
Scott Antonia of Oncology has received an award from Sanofi US for a project entitled "Establishing a Pipeline for the Discovery and Characterization of Novel Intra-Tumoral Antibodies in Patients with NSCLC." Total funding will be $150,000.
Niharika Mettu of Oncology has received an award from Pfizer, Inc. for a project entitled "A PHASE 1 OPEN-LABEL STUDY OF PF-07934040 AS A SINGLE-AGENT AND IN COMBINATION WITH OTHER TARGETED AGENTS IN PARTICIPANTS WITH ADVANCED SOLID TUMORS HARBORING MUTATIONS IN THE KRAS GENE." Total funding will be $649,391.
John Strickler of Oncology has received an award from Lilly USA, LLC for a project entitled "A Phase 1a/1b Study of the pan-KRAS Inhibitor LY4066434 in Participants with KRAS Mutant Solid Tumors (J5Q-OX-JRDA)." Total funding will be $683,599.
Aparna Swaminathan of Pulmonary has received an award from GB002, Inc. for a project entitled "US Patient Engagement." Total funding will be $82,529.